Active Ingredient History
Ecopipam is a dopamine antagonist which is under development for the treatment of Lesch-Nyhan syndrome, Tourette's syndrome, speech disorders, and restless legs syndrome. It is taken by mouth. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adolescent (Phase 2)
Childhood-Onset Fluency Disorder (Phase 2/Phase 3)
Communication Disorders (Phase 2/Phase 3)
Drug Interactions (Phase 1)
Gambling (Phase 2)
Healthy Volunteers (Phase 1)
Language Disorders (Phase 2/Phase 3)
Lesch-Nyhan Syndrome (Phase 3)
Pediatrics (Phase 2)
Restless Legs Syndrome (Phase 1/Phase 2)
Self-Injurious Behavior (Phase 3)
Speech Disorders (Phase 2/Phase 3)
Stuttering (Phase 2/Phase 3)
Tourette Syndrome (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue